<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00140504</url>
  </required_header>
  <id_info>
    <org_study_id>05-061</org_study_id>
    <secondary_id>Weingart - K08HS11644</secondary_id>
    <nct_id>NCT00140504</nct_id>
  </id_info>
  <brief_title>Preventing Adverse Drug Events With PatientSite</brief_title>
  <official_title>Preventing Adverse Drug Events With PatientSite</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dana-Farber Cancer Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Agency for Healthcare Research and Quality (AHRQ)</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>Blue Cross Blue Shield</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beth Israel Deaconess Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Dana-Farber Cancer Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a study to better understand the nature and extent of adverse drug events (ADEs),
      defined as injuries due to prescription medications, in primary care. We will study whether
      PatientSite (an internet-based communication program for patients and health care providers)
      can improve clinicians' ability to detect adverse drug events among primary care patients and
      to mitigate the consequences by sending electronic queries to patients after they receive new
      medication prescriptions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  A drug safety module called MedCheck was developed for PatientSite. This allows
           physicians to query patients automatically 10 days after they receive a new prescription
           asking them questions about their new prescription. In this study new enhancements will
           be tested.

        -  Participants will be assigned at random to the intervention group or control group. The
           intervention group will receive a single electronic PatientSite message asking them
           questions about the new prescription which is then forwarded to their physician. The
           control group will receive a generic message about medication safety.

        -  To identify adverse drug events, a telephone survey and medical record review will be
           conducted of patients in the intervention group and controls.

        -  This study will run for 12 months.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2003</start_date>
  <completion_date type="Actual">December 2004</completion_date>
  <primary_completion_date type="Actual">December 2004</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To prevent adverse drug events with PatientSite.</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improve patient satisfaction</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>better utilization of services</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>improve patient-clinician communication</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Adverse Drug Event</condition>
  <arm_group>
    <arm_group_label>MedCheck</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Electronic medication safety queries via PatientSite portal</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No electronic medication safety messages via PatientSite portal</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Medcheck message</intervention_name>
    <description>Participants selected at random will receive one email message asking them questions about their prescription which will be forwarded to their physician</description>
    <arm_group_label>MedCheck</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients &gt;18

          -  Patients that receive a new prescription

          -  Proficient in spoken and written english

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Saul N Weingart, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dana-Farber Cancer Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Beth Israel Deaconess Medical Center</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 30, 2005</study_first_submitted>
  <study_first_submitted_qc>August 31, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 1, 2005</study_first_posted>
  <last_update_submitted>February 24, 2013</last_update_submitted>
  <last_update_submitted_qc>February 24, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 26, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Dana-Farber Cancer Institute</investigator_affiliation>
    <investigator_full_name>Saul N. Weingart, MD, PhD</investigator_full_name>
    <investigator_title>VP for Quality Improvement and Patient Safety</investigator_title>
  </responsible_party>
  <keyword>Adverse drug event</keyword>
  <keyword>Patient safety</keyword>
  <keyword>Internet portal</keyword>
  <keyword>PatientSite</keyword>
  <keyword>Preventive health</keyword>
  <keyword>Primary care</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Drug-Related Side Effects and Adverse Reactions</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

